What are the different types of IUDs available in the U.S. How do IUDs work to prevent pregnancy. What are the potential side effects of using an IUD. How effective are IUDs compared to other contraceptive methods. Who can use an IUD for birth control.

Understanding Intrauterine Devices (IUDs): A Highly Effective Contraceptive Option

Intrauterine devices (IUDs) stand out as one of the most effective reversible contraceptive methods available to women in the United States. Classified as long-acting reversible contraception (LARCs), IUDs offer years of pregnancy prevention with a single insertion. Despite their long history in the U.S., IUDs have faced various controversies, from safety concerns in the 1970s to recent debates about their mechanism of action and cost-related issues.

Are IUDs a new contraceptive option? No, IUDs have been used for decades in the United States. However, the landscape of available IUDs has evolved significantly since the 1980s, when safety concerns led to the removal of all but one IUD from the market. The introduction of new-generation IUDs in 1988, following revised FDA safety and manufacturing requirements, marked a turning point in IUD availability and acceptance.

Types of IUDs: Copper vs. Hormonal Options

IUDs fall into two main categories: copper and hormonal. Currently, the FDA has approved five different IUDs for use in the United States. Each type offers unique benefits and potential side effects, catering to diverse contraceptive needs.

Copper IUD: ParaGard

• Available since 1988
• Effective for up to 10 years
• Hormone-free option
• Can be used as emergency contraception within 5 days of unprotected intercourse
• Potential side effects include abnormal menstrual bleeding and increased cramping

Hormonal IUDs

1. Mirena (available since 2001, effective for 5 years)
2. Skyla (available since 2013, effective for 3 years)
3. Liletta (available since 2015, effective for 6 years)
4. Kyleena (available since 2016, effective for 5 years)

How do hormonal IUDs differ from the copper IUD? Hormonal IUDs release small amounts of the progestin hormone levonorgestrel daily. They may cause inter-menstrual spotting in the early months but often lead to reduced menstrual blood loss over time. Potential hormone-related side effects include headaches, nausea, breast tenderness, depression, and cyst formation.

Mechanism of Action: How IUDs Prevent Pregnancy

IUDs are remarkably effective at preventing pregnancy, with a success rate of over 99%. But how exactly do they work? IUDs primarily affect the ovum and sperm to prevent fertilization. Contrary to some misconceptions, IUDs do not act as abortifacients and do not affect an established pregnancy.

Does the copper IUD work differently from hormonal IUDs? Yes, while both types prevent fertilization, they do so through different mechanisms. The copper IUD creates an environment that is toxic to sperm, while hormonal IUDs thicken cervical mucus and may suppress ovulation in some cases.

IUD Insertion and Removal: What to Expect

IUD insertion is a medical procedure that must be performed by a trained healthcare provider. The device is placed into the uterus through the cervix, and a follow-up visit is typically recommended to confirm proper placement. Removal of an IUD also requires a visit to a healthcare provider.

Is IUD insertion painful? Many women experience some discomfort or cramping during insertion, but the procedure is generally quick. Some providers may recommend taking pain relievers before the appointment to minimize discomfort.

Eligibility and FDA Approval: Who Can Use IUDs?

While initial FDA approvals for some IUDs were limited to women who had given birth (parous women), current practice and guidelines have expanded eligibility. All FDA-approved IUDs are now available to women regardless of whether they have had children.

Can nulliparous women use IUDs safely? Yes, research has shown that IUDs can be safely and effectively used by women who have never given birth. The Skyla IUD, in particular, was designed with a slightly smaller size to better accommodate nulliparous women.

IUDs as Emergency Contraception: A Lesser-Known Application

The copper IUD (ParaGard) offers a unique advantage as an emergency contraceptive option. When inserted within five days of unprotected intercourse or contraceptive failure, it is highly effective at preventing pregnancy.

Is the copper IUD more effective than emergency contraceptive pills? Yes, the copper IUD is more effective than emergency contraceptive pills for preventing pregnancy after unprotected sex. Additionally, its effectiveness is not affected by the woman’s weight, unlike some emergency contraceptive pills.

Cost and Access: Navigating Financial Barriers to IUD Use

One of the significant challenges associated with IUD use is the high upfront cost of the device and insertion procedure. However, efforts are being made to improve access and affordability.

How is the healthcare industry addressing IUD cost barriers? Initiatives like the development of Liletta, a low-cost IUD available to public health clinics through the 340B Drug Pricing Program, aim to make IUDs more accessible to a broader range of women. Additionally, the Affordable Care Act’s contraceptive coverage mandate has improved insurance coverage for IUDs, though variability in coverage still exists.

Debunking Myths: IUDs and Fertility

Despite their high effectiveness as contraceptives, IUDs do not have long-term effects on fertility. Once removed, fertility typically returns quickly, allowing women to conceive if desired.

Do IUDs cause infertility? No, modern IUDs do not cause infertility. The ability to conceive usually returns rapidly after IUD removal, making them an excellent option for women who want to delay pregnancy but preserve future fertility.

In conclusion, IUDs represent a highly effective, long-acting, and reversible contraceptive option for women in the United States. With various types available, from hormone-free copper devices to progestin-releasing options, IUDs can meet diverse contraceptive needs. While challenges related to cost and access persist, ongoing efforts aim to make these devices more widely available. As with any medical decision, women considering an IUD should consult with their healthcare provider to determine the most appropriate contraceptive choice for their individual circumstances.

Intrauterine Devices (IUDs): Access for Women in the U.S.

Intrauterine devices (IUDs) are one of the most effective forms of reversible contraception. IUDs, along with implants, are known as long-acting reversible contraception (LARCs) because they can be used to prevent pregnancy for several years. IUDs have been used in the U.S. for decades, but a safety controversy in the 1970s prompted the removal of all but one IUD from the U.S. market by 1986. The first new generation IUD was introduced to the U.S. market in 1988, following revised Food and Drug Administration (FDA) safety and manufacturing requirements. Recent controversies have focused on the mechanism of action of IUDs, the high upfront costs for the device, and variability in insurance coverage and access. This fact sheet reviews the various IUDs approved by the FDA, awareness, use, and availability of IUDs, and key issues in insurance coverage and financing of IUDs in the U.S.

What is an IUD?

IUDs are small devices placed into the uterus through the cervix by a trained medical provider to prevent pregnancy. A follow up visit is recommended post-insertion to confirm placement, and a visit to the provider is required for removal. IUDs are effective for three to 10 years, depending on the type of IUD. There are two major categories of IUDs – copper and hormonal – and within those categories, there are currently five IUDs approved by the FDA (Table 1). IUDs work by affecting the ovum and sperm to prevent fertilization and are more than 99% effective at preventing pregnancy. They do not protect against HIV and other sexually transmitted infections (STIs). IUDs do not affect an established pregnancy and do not act as an abortifacient.

Copper IUD	Available Since	Years Effective	Use and FDA Approval	Possible side effects
Copper IUD (Paragard)	1988	10 years	Approved only in parous women, but available to all women regardless of parity. Can be used as Emergency Contraception when inserted within 5 days.	Abnormal menstrual bleeding. Higher frequency or intensity of cramps/ pain.
Hormonal IUDs	Available Since	Years Effective	FDA Approval	Possible side effects
Mirena	2001	5 years	Approved only in parous women, but available to all women regardless of parity.	Inter-menstrual spotting in the early months. Reduces menstrual blood loss significantly. Hormone-related: headaches, nausea, breast tenderness, depression, cyst formation.
Skyla	2013	3 years	Approved for women regardless of parity.
Liletta	2015	6 years	Approved for women regardless of parity.
Kyleena	2016	5 years	Approved for women regardless of parity.

Non-Hormonal Copper-T Intrauterine Device

The copper IUD is a hormone-free T-shaped device wrapped in copper wire and is effective for up to 10 years.

• Marketed under the brand name ParaGard by Teva Women’s Health Pharmaceuticals, the copper IUD was approved by the FDA in 1984 and has been available in the US since 1988.
• The copper IUD begins working immediately after insertion and consequently does not require a woman to use a backup method of contraception after insertion. Because of this, the copper-IUD can also be used as emergency contraception within five days of unprotected intercourse or method failure and is more effective at preventing pregnancy than emergency contraceptive pills. Unlike Plan B emergency contraceptive pills, the effectiveness of IUDs does not vary based on a woman’s weight.
• Current evidence does not support prior theories that the copper IUD damages fertilized embryos or prevents implantation.

Hormonal Intrauterine Devices (LNG-IUD)

Four hormonal IUDs are available on the US market. They are also known as LNG-IUDs because they contain the progestin hormone levonorgestrel, which is released in small amounts each day. Today, most women who use IUDs use one of the hormonal products. Hormonal IUDs are not effective as emergency contraception.

• Mirena, manufactured by Bayer Healthcare Pharmaceuticals, is the hormonal IUD that has been on the market longest and is the most commonly used. In addition to preventing pregnancy, the FDA approved use of Mirena in women using this IUD as contraception to treat heavy menstrual bleeding. Mirena, as well as the copper IUD, are not FDA approved for women who have not had children (nulliparous), but research has found that they can be provided safely and effectively to these women.
• Skyla, also manufactured by Bayer, is slightly smaller than the Mirena, making it a better candidate for nulliparous women.
• Liletta was approved in 2015. Actavis in conjunction with Medicines360, a non-profit women’s pharmaceutical company, developed Liletta specifically to be low cost and available to public health clinics enrolled in the national 340B Drug Pricing Program at a significant discount. The 340B program provides reduced cost pharmaceuticals to providers that serve low-income populations. In 2019, the FDA approved Liletta for up to six years of use, making it the hormonal IUD with the longest approved duration.
• Kyleena, the newest IUD, was approved by the FDA in September 2016, and became available in October 2016. It’s also manufactured by Bayer and contains lower hormone levels than Mirena.

Use, Awareness, and Availability of IUDs

Use of IUDs in the U.S. has been increasing substantially since the early 2000s but is still lower than other methods. Attitudes regarding safety of IUDs have been shifting interest has grown, especially among younger providers and younger women who have less knowledge of the IUD controversies of the past.

Use

• Recent data estimates that 14% of women¹ who use contraception ages 15 to 44 used an IUD in 2015-2017.² Utilization among all women, but especially younger women, has risen (Figure 1).

Figure 1: IUD Utilization Over Time Among Women Ages 15-44 Who Used Contraception Within Previous 30 Days

• IUD use is highest among women ages 25 to 34, 60% higher than the use rate among women ages 20 to 24 (Figure 2).

FIgure 2: Share of Women Using IUDs in the Past Month by Age, 2015-2017

• Women with a Bachelor’s degree or higher, private insurance coverage, and women who have given birth are more likely to use IUDs compared to women without high school degrees, women who are uninsured or have Medicaid coverage, and women who have never given birth (Figure 3). While women with children report higher use of IUDs, this trend may be changing as newer IUDs are marketed to nulliparous women.

Figure 3: IUD Use in the Past Month, Among Women 15-44 Currently Using Contraception, 2015-2017

• Use of IUDs varies significantly between countries, but is higher in many other countries than in the U.S., especially western Europe where the Dalkon Shield, one of the products that resulted in harm to women in the U.S. in the 1970s, was never available.
• Since the FDA approved IUDs for younger women and those who have not had children, multiple provider groups including the American College of Obstetricians and Gynecologists (ACOG) and the American Academy of Pediatrics (AAP) have recommended the use of IUDs for all women.

Awareness and Availability

• A 2017 survey of providers found that almost all obstetricians and gynecologists (ob/gyns) provide IUDs in their practice (91%) and offer IUDs to patients under the age of 21 (92%). This is in contrast to findings from a 2013 survey that found that just two-thirds (63%) of ob/gyns who provided IUD services at that time believed IUDs were appropriate for nulliparous women and less than half (43%) believed they were appropriate for adolescents. This may reflect recent increases in provider education as well as approval of new IUDs targeted specifically towards younger women.
• Currently, many physicians require two visits for a woman seeking an IUD: a consultation and the follow up visit for insertion. Stocking IUDs onsite allows clinicians to provide same-day services to women, but some providers have been hesitant to stock IUDs because of the high upfront costs.
• Community health centers (CHCs) are an important source of care for many low-income and uninsured women of reproductive age. However, access to IUDs has been challenging for some CHCs due to a combination of reasons, including high upfront costs and limited training and staff capacity to provide IUDs. Over half of community health centers provide IUDs or implants as part of the family planning services they offer, meaning many women seeking services from clinics may not have immediate access to IUDs.

Post pregnancy

• Providing IUDs to women immediately following a delivery, miscarriage or abortion can be convenient and an effective strategy for averting unintended pregnancy. Women may be particularly motivated to begin using contraception in the immediate postpartum period, and data indicate women are more likely to obtain an IUD in the immediate postpartum period compared to a follow-up visit. Although expulsion rates of IUDs are higher for postpartum women, they are lower when the IUD is inserted approximately 10 minutes after the placental delivery than if the IUD is inserted up to four weeks after the birth.
• IUD insertion immediately postpartum is not common. A 2017 survey of providers found that only 19% of ob/gyns reported offering immediate postpartum IUDs. Some providers may be unaware that IUD insertion post-pregnancy is safe and effective. Less than half of ob/gyns interviewed in a 2013 study (46%) said an IUD could be inserted immediately after birth and only one-fifth (20%) said IUDs could be inserted after an abortion or a miscarriage. Women with IUDs have lower rates of repeat abortion than women who choose other methods.

Insurance Coverage and Financing of IUDs

The costs of IUDs have been a barrier to its use, for both patients and providers. Prices for an IUD typically range between $500 and $1,300, in addition to provider visits for insertion, removal and confirmation that the device was properly placed. While many insurance plans have covered IUDs for years, prior to the passage of the Affordable Care Act (ACA), women were likely to have out-of-pocket charges for the product as well as the associated visits. The ACA has eliminated these costs for many women.

Private Insurance

• The ACA includes a requirement that most private insurance plans must cover at least one type of all 18 FDA-approved contraceptive methods for women as prescribed without cost sharing. This means that most private plans (small and large group, self-funded, and individually purchased plans) must cover the copper IUD and at least one hormonal IUD at no cost to policy holders. Research has found two-thirds of women (64%) with private insurance paid $0 in out of pocket costs for an IUD in 2016, compared to 39% of women in 2012. Average out-of-pocket spending for IUDs went from $118 in 2012 to $28 in 2016. Studies have also found an increase in LARC initiation among women with private insurance coverage after the implementation of the ACA contraceptive mandate.
• Although insurers are required to cover at least one hormonal IUD, the plan determines which hormonal IUD is covered. Plans must cover an alternate hormonal IUD if medically necessary.
• Insurers can use medical management to help control costs and encourage beneficiaries to choose more affordable contraceptive methods. While insurers can require step therapy and prior authorization, federal guidance prohibits insurers from categorically restricting access to a method. Insurers can choose to cover generic contraceptives only while charging cost-sharing for the brand-name version, but since IUDs do not have a generic equivalent, the brand name version must be covered without cost sharing.

Medicaid

• Federal law requires Medicaid programs to cover family planning services and supplies without cost-sharing, but there are variations in coverage between states and between different Medicaid populations. For women enrolled in traditional Medicaid programs that were in place prior to the passage of the ACA, coverage of IUDs is determined by each state program. States policies may limit coverage to only certain brands or types or apply medical management protocols to restrict availability.
• Women who qualify for Medicaid under the ACA’s expansion of the program must receive coverage for both the copper and at least one hormonal IUD because the ACA requires these expansion programs to cover all FDA approved methods for women without cost-sharing, which is the same as the requirement for private insurance plans.
• States are considering and adopting a variety of payment policies to facilitate postpartum LARC insertion. Labor and delivery services are typically reimbursed through a single global fee and many providers have reported that the global fee is not sufficient to cover the costs of providing a LARC postpartum at the time of delivery or at the follow up postpartum visit. The absence of a separate fee or an increase in reimbursement has been a disincentive for some providers to provide postpartum LARC. Most states continue to reimburse hospitals through a global fee for postpartum LARC services.
• Currently, 26 states extend Medicaid coverage for family planning services, including contraception, to some uninsured women who do not qualify for full scope Medicaid. States retain the flexibility to decide whether and which IUDs are covered by these programs.

Uninsured

• The federal Title X National Family Planning Program funds a network of clinics to provide family planning care to millions of low-income and uninsured people at reduced or no cost. In previous years the Title X program had emphasized provision of LARCs, but 2019 regulations by the Trump administration now allow clinics that only provide a single family planning method to participate in the Title X program, “as long as the entire project offers a broad range of such family planning methods and services. ” This means that clinics that do not provide the full range of methods, including IUDs, may be included in the Title X program.
• Federal recommendations for Providing Quality Family Planning Services (QFP) released by the Centers for Disease Control and Office of Population Affairs recommend that providers offer the full range of FDA approved contraceptive methods to patients who wish to delay or postpone pregnancy. These guidelines recommend that providers talk to patients about their contraceptive options using a tiered approach—talking first about the most effective methods (which include IUDs and implants) before talking about less effective methods.
• As interest in LARC use has grown so have concerns around the promotion of LARCs as the “most effective” methods and the potential for coercion. Some people have reported that they have felt pressured to choose a method of contraception during contraceptive counseling, and have felt that their providers preferred and were even pushing them towards a LARC method. Others reported that their physicians have been resistant and even unwilling to remove their IUDs early. In one study, physicians reported having negative feelings about early IUD removal and some had encouraged patients not to remove their IUD early. Researchers have recommended that instead of first talking about LARCs and how effective they are, providers should first discuss with their patients their contraceptive preferences and reproductive goals, and help patients choose a contraceptive method that meets their lifestyle needs.
• Community health centers (CHCs) play a major role in providing reproductive health care to low-income people and medically underserved communities. CHCs are required to provide “voluntary family planning” services but have significant leeway in determining what specific services they provide. A 2017 survey of CHCs found that over half of sites provided LARC methods on-site—64% offered hormonal IUDs (such as Mirena, Skyla, Liletta) and 55% offered copper IUDs. The same survey found that sites that received Title X funds were consistently more likely to offer IUDs compared to sites that did not receive Title X funding.
• Some manufacturers operate programs that offer reduced price or fully subsidized IUDs for some low-income people. IUD manufacturers may also offer installment plans for those who purchase IUDs directly and have no other coverage.
• Studies have found young women are very likely to choose the most effective methods of contraception when cost barriers are removed. The Contraceptive CHOICE Project offered young women seeking care at Title X clinics in Colorado and at Washington University in St. Louis, contraception without cost-sharing. More than half of women chose an IUD as their method of contraception. Continuation rates among participants who chose IUDs (77-79%) were significantly higher than non-LARC users (41%) 24 months after choosing their method. High continuation rates among IUD users have been documented in other studies looking at national claims data.

Conclusion

IUDs are one of the most effective forms of reversible contraception and interest in continues to grow.   While use of IUDs is still relatively low compared to some other methods, the ACA’s requirement for coverage of contraceptive services and supplies without cost-sharing removes cost barriers for millions of women with private coverage. The elimination of the cost related barriers along with greater awareness and acceptance of IUDs among clinicians and patients will likely continue to increase the use of one of the most effective methods of contraceptive available in the U.S.

What is the Effectiveness of the IUD?

In This Section

• IUD

• How effective are IUDs?

• How can I get an IUD?

• What’s an IUD insertion like?

• Are there IUD side effects?

• How safe are IUDs?

• What are the benefits of IUDs?

• What are the disadvantages of IUDs?

• How does IUD removal work?

• What are hormonal IUDs?

• What are non-hormonal IUDs?

The IUD is almost mistake-proof, making it one of the most effective methods available.

How effective are IUDs when used as birth control?

IUDs are one of the best birth control methods out there — more than 99% effective. That means fewer than 1 out of 100 people who use an IUD will get pregnant each year.

IUDs are so effective because there’s no chance of making a mistake. You can’t forget to take it (like the pill), or use it incorrectly (like condoms). And you’re protected from pregnancy 24/7 for 3 to 12 years, depending on which kind you get. Once your IUD is in place, you can pretty much forget about it until it expires. You can keep track of your insertion and removal date using our birth control app. 

How effective are IUDs when used as emergency contraception?

The Paragard (copper), Mirena, and Liletta IUDs are the most effective method of emergency contraception available. If you get one of these IUDs put in within 120 hours (5 days) after having unprotected sex, it’s more than 99.9% effective at preventing pregnancy. Then, if you want to, you can keep it and have really effective birth control that you can use for up to 8 to 12 years (depending on which kind you get).

Do IUDs protect against STDs?

No, IUDs don’t protect against STDs. Luckily, using condoms or internal condoms every time you have sex does lower the chance of getting or spreading STDs. So using condoms with your IUD is the way to go.

Was this page helpful?

• Yes

• No

Help us improve – how could this information be more helpful?

How did this information help you?

Please answer below.

Are you human? (Sorry, we have to ask!)

Please don’t check this box if you are a human.

You’re the best! Thanks for your feedback.

Thanks for your feedback.

IUD

• 99% effective

• Costs up to $1,300, but can be $0

• Put in by a doctor or nurse

• Lasts up to 12 years

This IUD doesn’t protect you from STDs. Use a condom with your IUD to help stop pregnancy and STDs.

See All Methods

Back to top

Abstinence

Breastfeeding

Cervical Cap

Condom

Diaphragm

FAM

Implant

Internal Condom

IUD

The Patch

The Pill

The Ring

The Shot

Spermicide

Sponge

Sterilization

Vasectomy

Withdrawal

We couldn’t access your location, please search for a location.

Zip, City, or State

Please enter a valid 5-digit zip code or city or state.

Please fill out this field.

Service
All Services
Abortion

Abortion Referrals

Birth Control

COVID-19 Vaccine

HIV Services

Men’s Health Care

Mental Health

Morning-After Pill (Emergency Contraception)

Pregnancy Testing & Services

Primary Care

STD Testing, Treatment & Vaccines

Transgender Hormone Therapy

Women’s Health Care

Filter By
All
Telehealth
In-person

Please enter your age and the first day of your last period for more accurate abortion options. Your information is private and anonymous.

AGE

This field is required.

Or call
1-800-230-7526

Women — latest news today

Choose a date

2023

City dweller about 45 years old: about Belgorod women in terms of statistics

According to the 2020 census, more than 800 thousand women lived in the Belgorod region. Their average age was about 45 years. They were mostly city dwellers. Details are reported by Belgorodstat.

March 8 08:23

Are girls accepted in self-defense in the Belgorod region

Vyacheslav Gladkov answered the question of a local woman who decided to join the ranks of the defense. As it turned out, the fair sex is also involved in such activities.

7 March 20:01

In Belgorod, women will be congratulated by a video on the big screen

Anyone can record and send a video for free. The number by which records are accepted was provided by the administration of Belgorod.

March 7 16:21

2022

A father with a child in Belgorod was refused hospitalization because of only women in the ward

December 30, 2022, 08:21

employers are more likely to invite women for interviews

Due to the announcement of partial mobilization by the end of September, the number of such invitations increased by 3%, according to HeadHunter.

October 21, 2022, 15:17

A Belgorod man ingratiated himself with women and stole phones and money from them

The police became aware of two cases of theft. The attacker sold the stolen phones and spent the money, the regional Ministry of Internal Affairs reported.

July 13, 2022, 08:01

Specialists said about the infringement of women’s rights when paying in Russia

The National Research University Higher School of Economics calculated the gap in wages between men and women and came to the conclusion that there is a serious gender inequality in the country. This is reported by Novye Izvestia.

June 27, 2022, 12:51

A strategic session for women deputies was held in Belgorod

June 20, 2022, 10:30

Women drivers in Moscow have killed five people since the beginning of the year

90 002 June 3, 2022, 06:55

In Stary Oskol a woman beat her friend with a stool

She hit her friend on the head several times. The victim escaped with minor injuries, the woman’s health is not in danger. The incident was reported to the regional Ministry of Internal Affairs.

March 18, 2022, 11:22

829 thousand women are celebrated in the Belgorod region on March 8 March 2022, 05:58

Almost one hundred belgorodok want cars from city hall

March 1, 2022, 13:14

Belgorod residents can win a car or money in a competition from city hall

29 January 2022, 07:17

2021

To Belgorod oblast, 9,000 people have been victims of domestic violence since beginning of the year

October 15, 2021, 12:25

In the Belgorod region, women study online more often: Tele2 big data study 002 May 31, 2021 , 12:08

Now Russian women will be able to think for a year where to spend their mother’s capital

April 20, 2021, 14:19

2020

Four women were injured in an accident with a passenger bus in Belgorod. The details of the accident were told in the press service of the Ministry of Internal Affairs for the Belgorod Region.

November 20, 2020, 14:09

White Rose Charitable Medical Diagnostic Center for Women’s Health in Moscow

We strive to help everyone, regardless of status, age and social status.

Thank you for taking care of your health!

About the Center

The White Rose project was developed by the Foundation for Social and Cultural Initiatives in 2010 on the initiative and under the personal guidance of the President of the Foundation, Svetlana Vladimirovna Medvedeva.

The purpose of this project is to attract the attention of the public, especially women, to their own reproductive health as a guarantee of a prosperous, happy motherhood and a successful future. For this purpose, a network of charitable medical centers for the early diagnosis of oncological diseases of the reproductive sphere and mammary glands – “White Rose” is currently being built.

A distinctive feature of the White Rose centers is the creation of the most favorable atmosphere for patients in order to change the negative attitude of women towards preventive examinations. The centers provide for the provision of psychological assistance to women with suspected oncological pathology, as well as patronage, informational and psychological support for patients who need further examination or treatment.

Our services

Gynecologist’s consultation

It is with the gynecologist’s consultation that the comprehensive examination in White Rose begins. A gynecologist collects anamnesis, gynecological examination using special mirrors, performs other diagnostic procedures and forms a plan for further examination.

Consultation with a mammologist oncologist

Consultation with a mammologist is a key aspect of successful treatment of breast pathology. After analyzing all the diagnostic and clinical data, the doctor makes a conclusion about the woman’s health and, if necessary, develops a treatment plan.

Breast ultrasound

Is one of the main screening examinations for breast tumors (together with mammography and self-diagnosis). It also includes a mandatory scan of the lymph nodes of four zones: supraclavicular, subclavian, prothoracic and axillary. Preventive examination of the mammary glands is recommended after 30 years once a year, after 50 years – twice a year.

Ultrasound of the pelvic organs

This method is the main one in the diagnosis of tumors and cysts of the uterus and ovaries. Ultrasound examination allows you to examine the bladder and ureters, uterus, ovaries and fallopian tubes. In this case, either a superficial or intracavitary vaginal sensor is used.

Collection and examination of smears for oncocytology

A gynecologist collects cellular material for oncocytological examinations for the presence of cells with any pathological changes. A smear is a simple but highly accurate screening method that allows you to detect cancerous and precancerous changes in the epithelium of the cervix. Recommended for all women over 30.

Invasive examinations

In some cases, if the results of mammography or ultrasound indicate the presence of neoplasms in the breast, a biopsy, a laboratory study of a tissue sample from the breast, may be ordered. A biopsy allows you to find out if the tumor is malignant, as well as determine its type and stage.

Colposcopy

Diagnostic examination of the entrance to the vagina, vaginal walls and cervix with an enlarged image using a special device – a colposcope. Such a study improves the quality of diagnosis of precancerous diseases and early stages of cervical cancer.

Mammography

This X-ray examination is performed for the early detection of breast cancer. The use of a digital mammograph reduces radiation exposure to the body and ensures high image quality. The study is carried out according to indications in case of suspicion of any disease of the mammary glands. After the age of 40, it is recommended to have a regular mammogram once a year.

Patient School

We train our patients in self-examination techniques for the timely primary detection of suspicious changes in the mammary gland without specifying their nature. This allows you to contact a doctor in time, thereby ensuring early diagnosis of a possible disease and, accordingly, its successful treatment.

How to get tested?

Step 1

Call +7 495 236-10-10 . An appointment is made during working hours from 09:00 to 21:00, except weekends and holidays.

Step 2

Answer medical questions to the operator. Write down the date and time of your visit to the Center. Prepare passport , policy OMS and SNILS .

Step 3

Contact the Center reception 30-45 minutes before the appointed time in order to get a medical record.

Step 4

Schedule a date and time for a follow-up appointment with for a follow-up consultation.

Step 5

Have an examination by a gynecologist who will form a further examination plan.

Read more

White Rose news

All news

Charitable Medical Center “White Rose” opened in Tver

December 4 in Tver was the opening of the diagnostic center for women’s health “White Rose”.
President of the Foundation Svetlana Medvedeva, Governor of the Tver region Igor Rudenya, Metropolitan Savva of Tver and Kashin took part in the opening of the center.

January 16, 2020 at 10:17 pm

White Rose Women’s Reproductive Health Support Center opened in Ivanovo

For women, this is an opportunity to get tested faster. The centers are engaged not only in the detection of oncological diseases, but also in information and educational work so that the patient understands that she needs to undergo examinations, take care of her health as a mother, as a woman.

January 12, 2018 at 11:42 pm

“White Rose” emblem of hope in Murmansk

Nordic women no longer need to languish in endless queues to have their health checked. The new charitable medical diagnostic center “White Rose” helps them with this.

October 5, 2016 at 2:35 pm

in Orenburg opened a branch of the center “White Rose”

The White Rose Medical Center examines up to 1,500 women here every month. A branch of the center was opened on the basis of the second antenatal clinic in the village of South Orenburg.

September 26, 2016 at 2:58 pm

White Rose Centers in Russia

Moscow Region

Krasnogorsk

st. Mezhdunarodnaya, d.

+7 495 236-10-10

Opening hours: Mon-Sat 8:00 – 22:00

https://belroza.ru

St. Petersburg

• Moskovsky prospect, 104k3
• Moravsky Lane, 5

+7 812 748-23-56

Opening hours: Mon-Fri 8:30 am – 9:00 pm

http://fond-belaya-roza. ru/

Arkhangelsk

Trinity Avenue, 99

• +7 8182 47-20-36
• +7 8182 20-57-12

Opening hours: Mon-Fri 8:00 – 20:00

Murmansk

st. Academician Pavlova, d. 6, building. 4

+7 8152 56-70-70

Opening hours: Mon-Fri 08:00 – 18:00
Appointment by phone on Fridays from 12.00 to 16.00 for 1 week in advance

Website of the White Rose Center in Murmansk

Severodvinsk

Marine Avenue, 49

+7 953 267-56-19

Opening hours: Mon-Fri 9:00 – 17:00, appointment from 13:00 to 15:00

Yakutia

• Yakutsk, st. Mayakovsky, 84
• Neryungri, st. Churapchinskaya, 17

• Yakutsk +7 914 275-88-55
• Neryungri +7 924 766-88-55

Opening hours Yakutsk: Mon-Fri 8:00 — 20:00

Neryungri city opening hours: Mon-Fri 15:00 – 21:00

Главная

Blagoveshchensk

• Kalinina street, 2/2
• per. Uralova 3/1

• +7 4162 20-00-09
• +7 4162 20-00-10

Opening hours: Mon-Fri 8:30 am – 8:00 pm

http://br28.ru

Yuzhno-Sakhalinsk

st. Kurilskaya, 42a

• +7 4242 300-114
• +7 4242 300-115

http://bel-roza.ru/

Working hours: Mon-Fri 8:00 – 20:00

Kemerovo

Oktyabrsky prospect, 22B

st. Rukavishnikova, 22

• +7 3842 39-22-56
• +7 3842 39-22-66

Opening hours: Mon-Fri 9:00 – 19:00

http://br42.ru/

Orenburg

Pobedy Ave., 54

+7 3532 43-47-17

Working hours: Mon-Fri 8:00 – 19:00

http://belayaroza56.ru/

Ufa

st. Russian, 31

+7 347 244-60-05

Opening hours: Mon-Fri 8:00 – 20:00

https://belayaroza-ufa.ru/

Ivanovo

st. Stankostroiteley, 4

+7 4932 93-44-85

Working hours: Mon-Fri 8:00 – 20:00

Главная

Tver

Tverskoy prospect, 14

+7 4822 36-29-00

+7 495 128-60-69

Opening hours: Mon-Sat 9:00 – 21:00

http://br69.